Literature DB >> 33436812

Serum fibroblast growth factor 21 levels after out of hospital cardiac arrest are associated with neurological outcome.

Pirkka T Pekkarinen1, Markus B Skrifvars2, Ville Lievonen2, Pekka Jakkula3, Laura Albrecht2, Pekka Loisa4, Marjaana Tiainen5, Ville Pettilä3, Matti Reinikainen6, Johanna Hästbacka3.   

Abstract

Fibroblast growth factor (FGF) 21 is a marker associated with mitochondrial and cellular stress. Cardiac arrest causes mitochondrial stress, and we tested if FGF 21 would reflect the severity of hypoxia-reperfusion injury after cardiac arrest. We measured serum concentrations of FGF 21 in 112 patients on ICU admission and 24, 48 and 72 h after out-of-hospital cardiac arrest with shockable initial rhythm included in the COMACARE study (NCT02698917). All patients received targeted temperature management for 24 h. We defined 6-month cerebral performance category 1-2 as good and 3-5 as poor neurological outcome. We used samples from 40 non-critically ill emergency room patients as controls. We assessed group differences with the Mann Whitney U test and temporal differences with linear modeling with restricted maximum likelihood estimation. We used multivariate logistic regression to assess the independent predictive value of FGF 21 concentration for neurologic outcome. The median (inter-quartile range, IQR) FGF 21 concentration was 0.25 (0.094-0.91) ng/ml in controls, 0.79 (0.37-1.6) ng/ml in patients at ICU admission (P < 0.001 compared to controls) and peaked at 48 h [1.2 (0.46-2.5) ng/ml]. We found no association between arterial blood oxygen partial pressure and FGF 21 concentrations. We observed with linear modeling an effect of sample timepoint (F 5.6, P < 0.01), poor neurological outcome (F 6.1, P = 0.01), and their interaction (F 3.0, P = 0.03), on FGF 21 concentration. In multivariate logistic regression analysis, adjusting for relevant clinical covariates, higher average FGF 21 concentration during the first 72 h was independently associated with poor neurological outcome (odds ratio 1.60, 95% confidence interval 1.10-2.32). We conclude that post cardiac arrest patients experience cellular and mitochondrial stress, reflected as a systemic FGF 21 response. This response is higher with a more severe hypoxic injury but it is not exacerbated by hyperoxia.

Entities:  

Year:  2021        PMID: 33436812      PMCID: PMC7804444          DOI: 10.1038/s41598-020-80086-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  47 in total

Review 1.  Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis.

Authors:  Comilla Sasson; Mary A M Rogers; Jason Dahl; Arthur L Kellermann
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-11-10

2.  Admission interleukin-6 is associated with post resuscitation organ dysfunction and predicts long-term neurological outcome after out-of-hospital ventricular fibrillation.

Authors:  Jukka Vaahersalo; Markus B Skrifvars; Kari Pulkki; Mats Stridsberg; Helge Røsjø; Seppo Hovilehto; Marjaana Tiainen; Tero Varpula; Ville Pettilä; Esko Ruokonen
Journal:  Resuscitation       Date:  2014-09-17       Impact factor: 5.262

3.  Fibroblast growth factor 21 protects the heart from oxidative stress.

Authors:  Anna Planavila; Ibon Redondo-Angulo; Francesc Ribas; Gloria Garrabou; Jordi Casademont; Marta Giralt; Francesc Villarroya
Journal:  Cardiovasc Res       Date:  2014-12-23       Impact factor: 10.787

Review 4.  Postischemic oxidative stress promotes mitochondrial metabolic failure in neurons and astrocytes.

Authors:  Gary Fiskum; Camelia A Danilov; Zara Mehrabian; Linda L Bambrick; Tibor Kristian; Mary C McKenna; Irene Hopkins; E M Richards; Robert E Rosenthal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

5.  Proteomics in Hypothermia as Adjunctive Therapy in Patients with ST-Segment Elevation Myocardial Infarction: A CHILL-MI Substudy.

Authors:  Moman A Mohammad; Marco Noc; Irene Lang; Michael Holzer; Peter Clemmensen; Ulf Jensen; Bernhard Metzler; David Erlinge
Journal:  Ther Hypothermia Temp Manag       Date:  2017-03-02       Impact factor: 1.286

6.  High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study).

Authors:  Kwok Leung Ong; Nicholas Hui; Andrzej S Januszewski; Nadeem O Kaakoush; Aimin Xu; Rana Fayyad; David A DeMicco; Alicia J Jenkins; Anthony C Keech; David D Waters; Philip J Barter; Kerry-Anne Rye
Journal:  Metabolism       Date:  2018-11-16       Impact factor: 8.694

7.  The influence of induced hypothermia and delayed prognostication on the mode of death after cardiac arrest.

Authors:  Irina Dragancea; Malin Rundgren; Elisabet Englund; Hans Friberg; Tobias Cronberg
Journal:  Resuscitation       Date:  2012-09-20       Impact factor: 5.262

8.  Analysis of longitudinal data from animals with missing values using SPSS.

Authors:  Denise A Duricki; Sara Soleman; Lawrence D F Moon
Journal:  Nat Protoc       Date:  2016-05-19       Impact factor: 13.491

9.  Circulating Fibroblast Growth Factor 21 is Associated with Subsequent Renal Injury Events in Patients Undergoing Coronary Angiography.

Authors:  Cheng-Hsueh Wu; Ruey-Hsing Chou; Chin-Sung Kuo; Po-Hsun Huang; Chun-Chin Chang; Hsin-Bang Leu; Chin-Chou Huang; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

10.  FGF21 Protects Against Hypoxia Injury Through Inducing HSP72 in Cerebral Microvascular Endothelial Cells.

Authors:  Hao-Wei Wang; Xin Jiang; Yu Zhang; Jian Wang; Jian Xie; Yong-Qiang Wang; Yong-Hua Li
Journal:  Front Pharmacol       Date:  2019-02-20       Impact factor: 5.810

View more
  3 in total

1.  FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure.

Authors:  Salah Sommakia; Naredos H Almaw; Sandra H Lee; Dinesh K A Ramadurai; Iosif Taleb; Christos P Kyriakopoulos; Chris J Stubben; Jing Ling; Robert A Campbell; Rami A Alharethi; William T Caine; Sutip Navankasattusas; Guillaume L Hoareau; Anu E Abraham; James C Fang; Craig H Selzman; Stavros G Drakos; Dipayan Chaudhuri
Journal:  Circ Heart Fail       Date:  2021-12-06       Impact factor: 8.790

2.  Serum levels of the cold stress hormones FGF21 and GDF-15 after cardiac arrest in infants and children enrolled in single center therapeutic hypothermia clinical trials.

Authors:  Jeremy R Herrmann; Ericka L Fink; Anthony Fabio; Alicia K Au; Rachel P Berger; Keri Janesko-Feldman; Robert S B Clark; Patrick M Kochanek; Travis C Jackson
Journal:  Resuscitation       Date:  2021-11-22       Impact factor: 5.262

3.  Postoperative Dynamic of Leptin and Fibroblast Growth Factor 21 in 123 Patients Recovering from Cardiac Surgery.

Authors:  Da Liu; Danyal Ghani; Wilson Y Szeto; Krzysztof Laudanski
Journal:  Med Sci Monit       Date:  2022-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.